Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;39(3):123-133.
doi: 10.1177/87551225231172349. Epub 2023 May 22.

A Quasi-Experimental Evaluation of Single Trough-Based Area Under the Curve Guided Dosing on the Incidence of Vancomycin Associated Nephrotoxicity in Veteran Patients

Affiliations

A Quasi-Experimental Evaluation of Single Trough-Based Area Under the Curve Guided Dosing on the Incidence of Vancomycin Associated Nephrotoxicity in Veteran Patients

Tanvi Patil et al. J Pharm Technol. 2023 Jun.

Abstract

Background: Two common dosing strategies for vancomycin are trough-based and area under the curve (AUC)-based dosing. Objective: To compare the incidence of nephrotoxicity in trough-based dosing group with the single trough-based AUC dosing at the Salem VA Medical Center. Methods: This retrospective study included patients who received trough-based dosing of vancomycin between January 1, 2017, and January 1, 2019 (preimplementation group) and AUC-based dosing (postimplementation) between October 1, 2019, and October 1, 2021, at the Salem VA Medical Center. The primary outcome was nephrotoxicity at 96 hours, 7 days, and entire hospital length of stay (LOS). Secondary outcomes included 30-day readmission and all-cause mortality rates, cumulative doses at 24, 48, and 72 hours, and percentage of patients considered at goal (AUC 400-600 or trough between 10 and 20 mg/L). Propensity score (PS) matching was utilized to adjust for confounding. Results: After PS matching 100 patients were included in preimplementation and 95 patients in the postimplementation group. The average study patient was a 68-year-old white male. There was significant reduction in the risk of nephrotoxicity in postimplementation cohort at 96 hours (adjusted (a)HR: 0.28, 95% CI (0.12-0.66); 7 days (aHR: 0.39, 95% CI (0.18-0.85); and entire hospital LOS (aHR: 0.46, 95% CI (0.22-0.95). Secondary outcomes showed no difference between the groups except significantly higher proportion of patients were considered at therapeutic goal in the postimplementation cohort compared with pre-implementation cohort. Conclusion: This hypothesis generating study shows that AUC-based dosing calculated using single trough concentration may result in reduced rate of nephrotoxicity than trough-based dosing.

Keywords: AUC; nephrotoxicity; rough concentration; vancomycin; veterans.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Patient selection flowchart. Please note that patients were initially pulled using Structured Query language (SQL) and excluded based on the initial exclusions such as number of vancomycin doses, if they received dialysis during the hospital stay, if no trough level was available, or if patients had duplicate entry due to change in their wards, that is, step down from ICU to medical floors. After which 139 eligible patients from the post-implementation cohort were matched 1:1 using PS as described in the methods section of the manuscript resulting in 131 matched patients in each cohort Due to the limitation of SQL and Electronic medical records, manual review of charts resulted in additional exclusion criteria resulting in total of 95 patients in post-implementation cohort and 100 patients in pre-implementation cohort. Abbreviation: PS, Propensity Score.
Figure 2.
Figure 2.
(a) Time to nephrotoxicity at 96 hours. (b) Time to nephrotoxicity at 7 days. (c) Time to nephrotoxicity for hospital LOS. Abbreviation: LOS, length of stay.

References

    1. Jeffres MN.The whole price of vancomycin: toxicities, troughs, and time. Drugs. 2017;77(11):1143-1154. - PMC - PubMed
    1. Filippone EJ, Kraft WL, Farber JL.The nephrotoxicity of vancomycin. Clin Pharmacol Ther. 2017;102(3):459-469. - PMC - PubMed
    1. Rybak MJ, Le J, Lodise TP, et al.. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020;77(11):835-864. doi:10.1093/ajhp/zxaa036 - DOI - PubMed
    1. Baddour LM, Wilson WR, Bayer AS, et al.; American Heart Association Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Stroke Council. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435-1486. doi:10.1161/CIR.0000000000000296 - DOI - PubMed
    1. van Hal SJ, Paterson DL, Lodise TP.Systematic review and meta analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother. 2013;57(2):734-744. doi:10.1128/AAC.01568-12 - DOI - PMC - PubMed